Drugs Online |
 |
 | ||
|
Rosiglitazone Avandia |
|
| ||
Drugs Online » Prescription Drugs 14 » Rosiglitazone Avandia Rosiglitazone ((ROS-e-glit-a-zone)) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used alone or with another type of diabetes medicine such as metformin insulin a sulfonylurea or sulfonylurea plus metformin. Rosiglitazone is used for: Controlling blood sugar levels along with diet and exercise in patients with type 2 diabetes. Rosiglitazone is an oral diabetes medicine that help control blood sugar levels. Rosiglitazone is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes. Rosiglitazone maleate is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Rosiglitazone is used in the management of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus [NIDDM] or adult-onset diabetes). Buy Rosiglitazone Avandia and other Prescription Drugs 14 products online at Medstore. 3752
About Rosiglitazone Avandia: Product Type: Prescription Drugs 14 Rosiglitazone ( Avandia Generic Rosiglitazone ) Rosiglitazone (Avandia Generic Rosiglitazone) Avandia Generic Rosiglitazone 4mg Bottle ( 100 Tabs ) Avandia Generic Rosiglitazone Rosiglitazone
View more Prescription Drugs 14 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
